Encompass Health (NYSE:EHC) Declares Quarterly Dividend of US$0.17 Per Share

Encompass Health (NYSE:EHC) has seen a notable increase of 4.3% in its share price over the past month. This positive movement aligns with some of the company's recent announcements and broader market trends. Key developments include the affirmation of a quarterly dividend of $0.17 per share, and the positive earnings report released in early February, which highlighted increased sales and net income compared to the previous year. Furthermore, the company's plans for significant business expansion, including the opening of new hospitals, may have bolstered investor confidence. Despite the general market downturn, as reflected by declines in major indexes like the Dow and the S&P 500, Encompass Health's positive financial performance and forward-looking business expansions appear to have provided a buffer, contributing to its stock performance. The company has effectively managed to stand out amidst the challenging market dynamics and broader industry pressures.

Take a closer look at Encompass Health's potential here.

Encompass Health's total shareholder return over the past three years was an impressive 98.05%, indicating significant growth when dividends are included. This performance reflects a variety of influential factors. Among the most impactful were strategic corporate expansions, such as the planned opening of seven new hospitals in 2025, which likely boosted investor confidence. The completion of share repurchase activities by October 2023, involving over 6.11 million shares, could have further enhanced the stock's appeal by reducing outstanding shares and potentially increasing earnings per share.

Moreover, Encompass Health's earnings have seen a marked increase, with a 26.8% growth over the past year alone, outpacing the broader Healthcare industry's growth rate. The company's addition to major indices like the Russell 1000 Value-Defensive Index in July 2024 may have also contributed by increasing visibility and demand. Collectively, these developments helped Encompass Health outshine both the market and industry benchmarks in recent years.

• Analyze Encompass Health's fair value against its market price in our detailed valuation report—access it here.
• Gain insight into the risks facing Encompass Health and how they might influence its performance—click here to read more.
• Shareholder in Encompass Health? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com